Rocket Lab (NASDAQ:RKLB) Shares Up 1.1% – Still a Buy?

Rocket Lab Corporation (NASDAQ:RKLB)’s stock price was up 1.1% during mid-day trading on Thursday . The company traded as high as $64.90 and last traded at $63.81. 18,596,813 shares traded hands during mid-day trading, a decline of 20% from the average session volume of 23,305,494 shares. The stock had previously closed at $63.10.

Key Headlines Impacting Rocket Lab

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Rocket Lab successfully completed its 94th Electron mission, deploying Synspective’s StriX Earth-imaging satellite. The launch maintained a perfect record for Synspective missions and reinforced Electron’s reliability. Synspective also has 16 additional Electron launches booked through 2030, providing meaningful future demand. Rocket Lab launches 94th Electron mission
• Positive Sentiment: Berenberg initiated coverage with a Buy rating, arguing that the expanding space market and Rocket Lab’s launch, satellite and defense capabilities offer substantial long-term growth potential. Other bullish commentary highlighted the company’s record backlog and growing national-security opportunities. Rocket Lab rated Buy by Berenberg
• Positive Sentiment: ARK Invest, led by Cathie Wood, continued buying the dip, acquiring hundreds of thousands of RKLB shares across its ETFs. The purchases may have improved investor sentiment by signaling confidence despite the recent selloff. Cathie Wood buys Rocket Lab shares
• Neutral Sentiment: A broader space-sector rally ahead of SpaceX’s Starship test helped lift sentiment toward space stocks, including Rocket Lab, although the event is not directly tied to RKLB’s results. Space-sector rally ahead of Starship test
• Negative Sentiment: Blue Origin won NASA’s $700 million Mars communications contract, beating Rocket Lab. The loss highlights intense competition for large government programs and removes a potentially important growth opportunity. Blue Origin wins NASA Mars contract
• Negative Sentiment: Investors remain focused on Neutron risk. Rocket Lab is spending ahead of the medium-lift rocket, which has not yet flown, raising concerns about cash burn, delays and when the program will begin generating returns. Rocket Lab’s Neutron execution risk
• Negative Sentiment: Some analysts and technical indicators turned cautious: Rocket Lab received a downgrade, Bank of America reduced its price target to $110, and bearish momentum signals remain in place. Heavy insider selling, including an $8.8 million CFO sale, and concerns that the stock remains expensive also weigh on sentiment. Rocket Lab analyst downgrade

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on RKLB. Morgan Stanley restated an “overweight” rating on shares of Rocket Lab in a research report on Wednesday, July 8th. Piper Sandler started coverage on Rocket Lab in a report on Wednesday, July 15th. They set a “neutral” rating and a $83.00 target price for the company. Bank of America lowered their price target on Rocket Lab from $115.00 to $110.00 and set a “buy” rating on the stock in a research note on Monday. Berenberg Bank began coverage on Rocket Lab in a research note on Wednesday. They issued a “buy” rating and a $83.00 price objective for the company. Finally, Roth Capital set a $110.00 price objective on Rocket Lab in a research note on Tuesday, August 11th. Three analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $108.83.

Rocket Lab Stock Performance

The company has a current ratio of 5.48, a quick ratio of 4.98 and a debt-to-equity ratio of 0.01. The stock’s fifty day simple moving average is $75.98 and its 200 day simple moving average is $84.91. The company has a market cap of $38.18 billion, a price-to-earnings ratio of -236.32 and a beta of 2.61.

Rocket Lab (NASDAQ:RKLB) last issued its earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.02). The company had revenue of $234.07 million for the quarter, compared to analyst estimates of $231.62 million. Rocket Lab had a negative return on equity of 6.48% and a negative net margin of 21.51%. As a group, analysts anticipate that Rocket Lab Corporation will post -0.2 earnings per share for the current year.

Insider Activity at Rocket Lab

In other Rocket Lab news, insider Marvin Clevenger sold 15,051 shares of the company’s stock in a transaction on Monday, August 24th. The stock was sold at an average price of $69.63, for a total value of $1,048,001.13. Following the completion of the sale, the insider directly owned 458,924 shares in the company, valued at $31,954,878.12. This represents a 3.18% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Frank Klein sold 45,692 shares of the firm’s stock in a transaction on Monday, August 24th. The stock was sold at an average price of $69.63, for a total value of $3,181,533.96. Following the completion of the sale, the insider directly owned 961,295 shares of the company’s stock, valued at $66,934,970.85. This trade represents a 4.54% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 3,484,214 shares of company stock valued at $304,166,848 in the last three months. Company insiders own 8.40% of the company’s stock.

Hedge Funds Weigh In On Rocket Lab

Institutional investors have recently bought and sold shares of the company. Anchor Capital Advisors LLC acquired a new position in Rocket Lab in the second quarter valued at about $1,421,000. Corient Private Wealth LP increased its position in shares of Rocket Lab by 795.2% during the second quarter. Corient Private Wealth LP now owns 476,241 shares of the rocket manufacturer’s stock valued at $48,410,000 after acquiring an additional 423,039 shares during the last quarter. Amundi increased its position in shares of Rocket Lab by 22.2% during the second quarter. Amundi now owns 2,180,748 shares of the rocket manufacturer’s stock valued at $221,673,000 after acquiring an additional 396,639 shares during the last quarter. HighTower Advisors LLC raised its stake in shares of Rocket Lab by 4.2% in the 2nd quarter. HighTower Advisors LLC now owns 109,226 shares of the rocket manufacturer’s stock valued at $11,103,000 after acquiring an additional 4,407 shares during the period. Finally, Groupe la Francaise purchased a new stake in shares of Rocket Lab in the 2nd quarter valued at approximately $725,000. 71.78% of the stock is owned by hedge funds and other institutional investors.

About Rocket Lab

Rocket Lab is an aerospace company that provides launch services, spacecraft, and space systems for commercial and government customers. The company’s primary launch vehicle is Electron, a small-lift orbital rocket designed to deploy small satellites and rideshare payloads to low Earth orbit. Rocket Lab also develops and manufactures the Rutherford engine, noted for its electric-pump-fed design and additive-manufactured components, which powers Electron and supports the company’s propulsion capabilities.